Human papillomavirus 18 as a poor prognostic factor in stage I-IIA cervical cancer following primary surgical treatment

키워드

참고문헌 (24)

1. Ferlay J, "GLOBOCAN 2008: cancer incidence, mortality, and prevalence worldwide" (2008), IARD Press
2. Jemal A, "Cancer statistics, 2010", CA Cancer J Clin, 60, pp.277~300 (2010)
3. 김영탁, "Current status of cervical cancer and HPV infection in Korea", Journal of Gynecologic Oncology, 20(1), pp.1~7 (2009), 대한부인종양학회
4. Munoz N, "Epidemiologic classification of human papillomavirus types associated with cervical cancer", N Engl J Med, 348, pp.518~527 (2003)
5. Van Muyden RC, "Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study", Cancer, 85, pp.2011~2016 (1999)
6. Walboomers JM, "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide", J Pathol, 189, pp.12~19 (1999)
7. Zur Hausen H, "Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis", J Natl Cancer Inst, 92, pp.690~698 (2000)
8. Rose BR, "Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: a possible role for type 18", Am J Obstet Gynecol, 173, pp.1461~1468 (1995)
9. Nakagawa S, "Type of human papillomavirus is related to clinical features of cervical carcinoma", Cancer, 78, pp.1935~1941 (1996)
10. Burger RA, "Human papillomavirus type 18:association with poor prognosis in early stage cervical cancer", J Natl Cancer Inst, 88, pp.1361~1368 (1996)
11. Lombard I, "Human papillomavirus genotype as a major determinant of the course of cervical cancer", J Clin Oncol, 16, pp.2613~2619 (1998)
12. Schwartz SM, "Human papillomavirus and prognosis of invasive cervical cancer: a populationbased study", J Clin Oncol, 19, pp.1906~1915 (2001)
13. Im SS, "Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion", Clin Cancer Res, 9, pp.4145~4150 (2003)
14. Viladiu P, "Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer", J Clin Oncol, 15, pp.610~619 (1997)
15. Huang LW, "Human papillomavirus-31-related types predict better survival in cervical carcinoma", Cancer, 100, pp.327~334 (2004)
16. Lai HC, "Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types", Int J Cancer, 84, pp.553~557 (1999)
17. Van Bommel PF, "HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancer", Gynecol Oncol, 48, pp.333~337 (1993)
18. Fule T, "Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes", Gynecol Oncol, 100, pp.570~578 (2006)
19. Rustin GJ, "Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer)", J Natl Cancer Inst, 96, pp.487~488 (2004)
20. Eisenhauer EA, "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)", Eur J Cancer, 45, pp.228~247 (2009)
21. Pilch H, "The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University", Int J Gynecol Cancer, 11, pp.39~48 (2001)
22. Bachtiary B, "Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer", Int J Cancer, 102, pp.237~243 (2002)
23. Kang WD, "HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy", Gynecol Oncol, 121, pp.546~550 (2011)
24. Peters WA 3rd, "Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix", J Clin Oncol, 18, pp.1606~1613 (2000)

관련 논문AI추천